| http://dbpedia.org/ontology/abstract
|
Валопицитаби́н (NM-283) — противовирусный … Валопицитаби́н (NM-283) — противовирусный препарат, разработанный для лечения гепатита С, прошедший клинические испытания фазы III. Он действует как ингибитор РНК-зависимой РНК-полимеразы. Это пролекарство, которое внутри организма превращается в активную форму — 2'-C-метилцитидинтрифосфат.тивную форму — 2'-C-метилцитидинтрифосфат.
, Valopicitabine (NM-283) is an antiviral dr … Valopicitabine (NM-283) is an antiviral drug which was developed as a treatment for hepatitis C, though only progressed as far as Phase III clinical trials. It acts as a RNA-dependent RNA polymerase inhibitor. It is a prodrug which is converted inside the body to the active form, 2'-C-methylcytidine triphosphate.ve form, 2'-C-methylcytidine triphosphate.
|
| http://dbpedia.org/ontology/casNumber
|
640281-90-9
|
| http://dbpedia.org/ontology/chEMBL
|
1743757
|
| http://dbpedia.org/ontology/drugbank
|
DB13920
|
| http://dbpedia.org/ontology/fdaUniiCode
|
I2T0B5G94M
|
| http://dbpedia.org/ontology/kegg
|
D09028
|
| http://dbpedia.org/ontology/pubchem
|
6918726
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Valopicitabine_structure.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
63552879
|
| http://dbpedia.org/ontology/wikiPageLength
|
3320
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1123464079
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/Antiviral_drug +
, http://dbpedia.org/resource/Category:Antiviral_drugs +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/RNA_polymerase +
, http://dbpedia.org/resource/Prodrug +
, http://dbpedia.org/resource/Category:Anti%E2%80%93RNA_virus_drugs +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/c
|
15
|
| http://dbpedia.org/property/casNumber
|
640281
|
| http://dbpedia.org/property/chembl
|
1743757
|
| http://dbpedia.org/property/chemspiderid
|
5293918
|
| http://dbpedia.org/property/drugbank
|
DB13920
|
| http://dbpedia.org/property/h
|
24
|
| http://dbpedia.org/property/iupacName
|
[-5--4-hydroxy-2--4-methyloxolan-3-yl] -2-amino-3-methylbutanoate
|
| http://dbpedia.org/property/kegg
|
D09028
|
| http://dbpedia.org/property/legalUs
|
Investigational drug
|
| http://dbpedia.org/property/molecularWeight
|
356.37
|
| http://dbpedia.org/property/n
|
4
|
| http://dbpedia.org/property/o
|
6
|
| http://dbpedia.org/property/pubchem
|
6918726
|
| http://dbpedia.org/property/smiles
|
CC[C@@H]N
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
TVRCRTJYMVTEFS-ICGCPXGVSA-N
|
| http://dbpedia.org/property/unii
|
I2T0B5G94M
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Antiinfective-drug-stub +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:RNA_antivirals +
, http://dbpedia.org/resource/Template:Drugbox +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Anti%E2%80%93RNA_virus_drugs +
, http://dbpedia.org/resource/Category:Antiviral_drugs +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Valopicitabine?oldid=1123464079&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Valopicitabine_structure.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Valopicitabine +
|
| owl:sameAs |
http://fa.dbpedia.org/resource/%D9%88%D8%A7%D9%84%D9%88%D9%BE%DB%8C%E2%80%8C%D8%B3%DB%8C%D8%AA%D8%A7%D8%A8%DB%8C%D9%86 +
, http://ru.dbpedia.org/resource/%D0%92%D0%B0%D0%BB%D0%BE%D0%BF%D0%B8%D1%86%D0%B8%D1%82%D0%B0%D0%B1%D0%B8%D0%BD +
, http://www.wikidata.org/entity/Q27280296 +
, https://global.dbpedia.org/id/2Z6VA +
, http://dbpedia.org/resource/Valopicitabine +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
Валопицитаби́н (NM-283) — противовирусный … Валопицитаби́н (NM-283) — противовирусный препарат, разработанный для лечения гепатита С, прошедший клинические испытания фазы III. Он действует как ингибитор РНК-зависимой РНК-полимеразы. Это пролекарство, которое внутри организма превращается в активную форму — 2'-C-метилцитидинтрифосфат.тивную форму — 2'-C-метилцитидинтрифосфат.
, Valopicitabine (NM-283) is an antiviral dr … Valopicitabine (NM-283) is an antiviral drug which was developed as a treatment for hepatitis C, though only progressed as far as Phase III clinical trials. It acts as a RNA-dependent RNA polymerase inhibitor. It is a prodrug which is converted inside the body to the active form, 2'-C-methylcytidine triphosphate.ve form, 2'-C-methylcytidine triphosphate.
|
| rdfs:label |
Valopicitabine
, Валопицитабин
|
